Learn more about the Registry
Alternatively, call the registry team toll-free at 1-877-390-2940 (hours of operation 8.30am – 5.00 pm EST Monday-Friday) or email at ritlecitinibpregnancyregistry@ppd.com
The Ritlecitinib Pregnancy Registry
Are you pregnant and diagnosed with alopecia areata? Have you taken Litfulo™ (ritlecitinib) or other medications for the treatment of alopecia areata during your pregnancy?
Alopecia areata can be a frustrating and emotionally difficult condition. Help future pregnant patients, doctors, and researchers understand the safety of medications that treat alopecia areata.
Are you a healthcare provider who treats pregnant patients with alopecia areata?
Help us learn more about the safety of using Litfulo™ (ritlecitinib) and other medications for the treatment of alopecia areata during pregnancy.
About The Ritlecitinib Pregnancy Registry
A pregnancy registry is a study that collects health information from women who use prescription medicines or vaccines when they are pregnant. Information is also collected from pregnant patients who do not take medications and from the newborn baby.
The goal of The Ritlecitinib Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of Litfulo™ (ritlecitinib) when used during pregnancy. However, pregnant patients with alopecia areata who have taken other medications, as well as those who have not taken any medications during pregnancy may be eligible to participate. The study collects health information from enrolled pregnant patients and their healthcare providers related to their pregnancies and developing babies up to 1 year of age.
Would you like to participate?
